TNF blockers on every 2026 American Samoa Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 1 stand-alone Part D plans in American Samoa cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
| Drug | AARP Medicare Rx Preferred from UHC$0.00/moS5820-034 |
|---|---|
| Humiraadalimumab | Not covered |
| adalimumab biosimilarsadalimumab-adaz, -fkjp, -aacf and others | Tier 5PA25% |
| Hadlimaadalimumab-bwwd | Not covered |
| Hyrimozadalimumab-adaz | Not covered |
| Cyltezoadalimumab-adbm | Not covered |
| Simlandiadalimumab-ryvk | Not covered |
| Yuflymaadalimumab-aaty | Not covered |
| Amjevitaadalimumab-atto | Not covered |
| Enbreletanercept | Tier 5PA25%QL 4/28d |
| Cimziacertolizumab pegol | Not covered |
| Simponigolimumab | Not covered |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.